Ultragenyx Pharma (RARE) Misses Q2 EPS by 51c; Reaffirms Product Revenue Guidance
Go back to Ultragenyx Pharma (RARE) Misses Q2 EPS by 51c; Reaffirms Product Revenue Guidance| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 26.49 +0.11 (0.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.38 | 52 Week High | $117.12 | |||
| Open | $26.30 | 52 Week Low | $46.52 | |||
| Day High | $26.58 | P/E | N/A | |||
| Day Low | $25.75 | EPS | $-1.97 | |||
| Volume | 1,221,938 | |||||
